Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 606 across all filing types
Latest filing 2023-01-27 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1930 characters) and contains the header 'RNS Number : 1490O' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific, short-form regulatory market announcement regarding trading status, not a comprehensive financial report or a standard corporate filing like 10-K or ER. Since it is a direct, immediate announcement disseminated via the RNS system that doesn't fit into the more specific categories (like DIV, DIRS, or ER), it falls best under the general 'Regulatory Filings' fallback category.
2023-01-27 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1913 characters) and contains the header 'RNS Number : 1486O'. It announces a 'Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly mentions RNS as the news service approved by the Financial Conduct Authority (FCA). Since this is a specific, non-standard regulatory announcement that doesn't fit into the defined categories like ER, 10-K, or DIV, and it originates from the RNS system, it should be classified under the general regulatory filing category.
2023-01-27 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1930 characters) and contains the header 'RNS Number : 0213O' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement. This type of short, time-sensitive regulatory update that doesn't fit into the major financial reporting categories (like 10-K, ER, IR) is best classified as a general Regulatory Filing (RNS), as per the definitions and the 'MENU VS MEAL' rule suggesting short announcements default to RNS/RPA if they aren't the main report.
2023-01-26 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1913 characters) and contains the header 'RNS Number : 0201O'. It announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or MANG), the most appropriate classification is the general regulatory filing fallback.
2023-01-26 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1930 characters) and contains the header 'RNS Number : 0104O' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement. Since it is a brief regulatory announcement distributed via the RNS system and does not fit into the specific categories like DIV, DIRS, or ER, it falls best under the general regulatory announcement category, RNS, as per the definitions and the 'MENU VS MEAL' rule (it's an announcement, not a full report).
2023-01-26 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1913 characters) and contains the header 'RNS Number : 0091O'. It announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or CAP), the most appropriate classification is the general regulatory filing fallback.
2023-01-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.